Key points from article :
Neuralink, the Elon Musk-founded company developing brain implants, has raised $280 million in a new funding round.
The funding was led by Founders Fund, a venture capital firm co-founded by Peter Thiel.
Despite earlier delays and skepticism from some former employees, Neuralink has now received FDA's green light for trials.
The new funding will be used to support Neuralink's clinical trials of its brain implant.
This latest funding round increases Neuralink's total funding well beyond the half-billion-dollar mark.
Neuralink has yet to begin enrolment for the clinical trial, but interested individuals can enrol in its registry.
